11 beta-Hydroxysteroid Dehydrogenase Type 1 is Overexpressed in Subcutaneous Adipose Tissue of Morbidly Obese Patients
dc.contributor.author | Munoz, Rodrigo | |
dc.contributor.author | Carvajal, Cristian | |
dc.contributor.author | Escalona, Alex | |
dc.contributor.author | Boza, Camilo | |
dc.contributor.author | Perez, Gustavo | |
dc.contributor.author | Ibanez, Luis | |
dc.contributor.author | Fardella, Carlos | |
dc.date.accessioned | 2024-01-10T12:37:20Z | |
dc.date.available | 2024-01-10T12:37:20Z | |
dc.date.issued | 2009 | |
dc.description.abstract | 11 beta-Hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) enzyme catalyzes interconversion of inactive cortisone to active cortisol. Its expression in adipose tissue has been associated with obesity and some of its metabolic disorders. Controversies regarding which fat depots [subcutaneous adipose tissue (SAT) or visceral adipose tissue (VAT)] have higher expression still remain. The aim of this work was to evaluate 11 beta-HSD1 expression in SAT and VAT of obese patients and evaluate its association to metabolic features of metabolic syndrome. | |
dc.description.abstract | In 32 morbidly obese patients, paired samples of SAT and VAT were collected. All patients, 40.2 +/- 12.3 years and 36.7 +/- 3.8 body mass index (BMI), underwent sleeve gastrectomy or laparoscopic gastric bypass. Gene expression of 11 beta-HSD1 in adipose tissue samples were determined by real-time reverse transcriptase polymerase chain reaction. Spearman correlation test was used to evaluate relationships between 11 beta-HSD1 levels and clinical and biochemical parameters. | |
dc.description.abstract | 11 beta-HSD1 mRNA levels were higher in SAT than in VAT, with median expression levels of 11.4 arbitrary units (AU) and 7.8 AU, respectively (p = 0.03). SAT 11 beta-HSD1 mRNA were correlated with VAT mRNA levels (r = -0.6, p = 0.018) and hip circumference (r = 0.66, p = 0.018). SAT 11 beta-HSD1 levels increase parallel according to BMI category. We did not find a correlation between SAT or VAT with fasting glucose (r = 0.15, p = NS), total cholesterol (r = 0.13, p = NS), triglycerides (r = 0.04, p = NS), and high-density lipoprotein (r = -0.16, p = NS). However, SAT expression in patients with features of MS was higher than those without features of MS. | |
dc.description.abstract | Our results demonstrate that SATs express higher 11 beta-HSD1 mRNA levels than VAT. This finding highlights the importance of SAT in obesity and its possible role on metabolic disorders associated with obesity. | |
dc.description.funder | FONDECYT | |
dc.description.funder | MECESUP | |
dc.description.funder | Pontificia Universidad Catolica de Chile | |
dc.fechaingreso.objetodigital | 2024-03-14 | |
dc.format.extent | 7 páginas | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.1007/s11695-008-9616-6 | |
dc.identifier.eissn | 1708-0428 | |
dc.identifier.issn | 0960-8923 | |
dc.identifier.pubmedid | MEDLINE:18592327 | |
dc.identifier.uri | https://doi.org/10.1007/s11695-008-9616-6 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/76822 | |
dc.identifier.wosid | WOS:000266262500013 | |
dc.information.autoruc | Medicina;Boza C;S/I;761 | |
dc.information.autoruc | Medicina;Carvajal C;S/I;8586 | |
dc.information.autoruc | Medicina;Escalona A;S/I;94025 | |
dc.information.autoruc | Medicina;Fardella C;S/I;66235 | |
dc.information.autoruc | Medicina;Ibáñez L;S/I;99661 | |
dc.information.autoruc | Medicina;Pérez G;S/I;5510 | |
dc.issue.numero | 6 | |
dc.language.iso | en | |
dc.nota.acceso | Contenido parcial | |
dc.pagina.final | 770 | |
dc.pagina.inicio | 764 | |
dc.publisher | SPRINGER | |
dc.revista | OBESITY SURGERY | |
dc.rights | acceso restringido | |
dc.subject | Adipose tissue | |
dc.subject | 11 beta-Hydroxysteroid dehydrogenase type 1 | |
dc.subject | Morbid obesity | |
dc.subject | Glucocorticoid | |
dc.subject | Cortisol | |
dc.subject | CORONARY-HEART-DISEASE | |
dc.subject | BODY-FAT DISTRIBUTION | |
dc.subject | NECROSIS-FACTOR-ALPHA | |
dc.subject | DIABETES-MELLITUS | |
dc.subject | REGIONAL DIFFERENCES | |
dc.subject | PROVISIONAL REPORT | |
dc.subject | METABOLIC-SYNDROME | |
dc.subject | LIPASE ACTIVITY | |
dc.subject | CELL SIZE | |
dc.subject | EXPRESSION | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | 11 beta-Hydroxysteroid Dehydrogenase Type 1 is Overexpressed in Subcutaneous Adipose Tissue of Morbidly Obese Patients | |
dc.type | artículo | |
dc.volumen | 19 | |
sipa.codpersvinculados | 761 | |
sipa.codpersvinculados | 8586 | |
sipa.codpersvinculados | 94025 | |
sipa.codpersvinculados | 66235 | |
sipa.codpersvinculados | 99661 | |
sipa.codpersvinculados | 5510 | |
sipa.index | WOS | |
sipa.index | Scopus | |
sipa.trazabilidad | Carga SIPA;09-01-2024 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 2024-03-14. 11β-Hydroxysteroid Dehydrogenase Type 1 is Overexpressed in Subcutaneous Adipose Tissue of Morbidly Obese Patients.pdf
- Size:
- 133.19 KB
- Format:
- Adobe Portable Document Format
- Description: